Empagliflozin Treatment Ameliorates the Inflammatory Profile of type 2 Diabetic Patients and reduce NFkB Expression by Promoting an Antioxidant Response in Leukocytes
Titel:
Empagliflozin Treatment Ameliorates the Inflammatory Profile of type 2 Diabetic Patients and reduce NFkB Expression by Promoting an Antioxidant Response in Leukocytes
Auteur:
Canet, Francisco de Marañón, Aranzazu M. Díaz-Pozo, Pedro Iannantuoni, Francesca Vezza, Teresa Abad-Jiménez, Zaida López-Domènech, Sandra Falcón, Rosa Zaragozá, Begoña Bañuls, Celia Sola, Eva Morillas, Carlos Rocha, Milagros Víctor, Víctor M.